These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 11277999)

  • 1. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
    Schempp CM; Simon-Haarhaus B; Termeer CC; Simon JC
    FEBS Lett; 2001 Mar; 493(1):26-30. PubMed ID: 11277999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL.
    Kim IK; Chung CW; Woo HN; Hong GS; Nagata S; Jung YK
    Biochem Biophys Res Commun; 2000 Oct; 277(2):311-6. PubMed ID: 11032723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK
    Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis.
    Matsui H; Hikichi Y; Tsuji I; Yamada T; Shintani Y
    J Biol Chem; 2002 Dec; 277(51):50054-61. PubMed ID: 12393901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway.
    Zhu H; Ling W; Hu B; Su Y; Qiu S; Xiao W; Qi Y
    Cancer Biol Ther; 2006 Feb; 5(2):180-8. PubMed ID: 16357524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
    Ballestrero A; Nencioni A; Boy D; Rocco I; Garuti A; Mela GS; Van Parijs L; Brossart P; Wesselborg S; Patrone F
    Clin Cancer Res; 2004 Feb; 10(4):1463-70. PubMed ID: 14977850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM
    Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.
    Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y
    Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.
    Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC
    Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells.
    Mariani SM; Matiba B; Armandola EA; Krammer PH
    J Cell Biol; 1997 Apr; 137(1):221-9. PubMed ID: 9105050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
    Ahmad M; Shi Y
    Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.